Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Diarrhoea, Dizziness, Dyspnoea, Fatigue, Hyperacusis
Clinical narrative: She thinks she had a delayed anaphylactic shock she was definitely in shock; hypothermic; her adrenal glands are over compensating, working over load; she was having diarrhea; throwing up; she went from cold to profusely sweating back to having chills; she went from cold to profusely sweating back to having chills; she had no blood to her extremities; severe abdominal cramps; headache; her body is just weak; she was feeling dizzy; Her legs were cramping; her heart was racing fast; her lactic acid was really high; This is a spontaneous report from a contactable Nurse.     A 53-years-old female patient  receive the first dose of bnt162b2 (BNT162B2; Lot # EL3249) vaccine , via an unspecified route of administration in the right deltoid  on  13Jan2021 15:55 at single dose for Covid-19 immunisation .  Medical history included hypertonic bladder from an unknown date., drug hypersensitivity from an unknown date , migraine from an unknown date. She had migraines.  Concomitant medication included solifenacin succinate (VESICARE), buspirone hydrochloride (BUSPAR), spironolactone (SPIRONOLACTONE).  The patient previously took flu vaccine VII, bactrim and experienced drug hypersensitivity.  The patient stated she thinks she had a delayed anaphylactic shock she was definitely in shock  on an unknown date  with outcome of unknown , hypothermic  on an unspecified date with outcome of unknown , her adrenal glands are over compensating, working over load  on an unspecified date with outcome of unknown , she was having diarrhea  on an unspecified date with outcome of not recovered , throwing up  on an unspecified date with outcome of unknown , she went from cold to profusely sweating back to having chills  on an unspecified date with outcome of unknown , she had no blood to her extremities  on an unspecified date with outcome of unknown , severe abdominal cramps on an unspecified date with outcome of unknown , headache  on an unspecified date with outcome of not recovered , her lactic acid was really high on 18Jan2021 with outcome of unknown , her body is just weak  on an unspecified date with outcome of not recovered , her heart was racing fast on 18Jan2021 with outcome of unknown , she was feeling dizzy  on 22Jan2021 with outcome of unknown , her legs were cramping  on 19Jan2021 with outcome of unknown.  The patient was hospitalized because of the events from 16Jan2021 to 17Jan2021.   The patient underwent lab tests and procedures which included blood lactic acid: high   on unknown date, chest x-ray: unknown results   on  unknown date, computerised tomogram: unknown results   on 18Jan2021   , electrocardiogram: unknown results   on unknown date.  The patient was given  fluids, Toradol and  Xanax to treat the events.  Further information has been requested.; Sender's Comments: Based on the available information, contributory role of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) to the onset of reported events cannot be completely excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate